// App-Quantinova.ai

Filters

Biomarkers











Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























7277 Abstracts

Bioresorbable Polymer Coated Thin Strut Sirolimus Eluting Stent Versus Durable Polymer Coated Everolimus Eluting Stent in Daily Clinical Practice: 1-Year Results from Interventional Cardiology Network Registry

Pawel Gasior - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Acute Thrombogenicity and Inflammation in Response to a Durable Fluoropolymer Everolimus-Eluting Stent Relative to a Contemporary Sirolimus-Eluting Stent with an Abluminal Biodegradable Polymer Coating

Sho Torii - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Clinical outcomes following novel abluminal coated sirolimus eluting stent implantation in small vessel vs. large vessel

Sameer Dani - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Comparison biolimus- and everolimus-eluting stents in patients with complex lesions. Five year follow-up from the COMPARE II trial

Valeria Paradies - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

A Randomized Comparison of Biodegradable Polymer- and Permanent Polymer-coated Platinum Chromium Everolimus-Eluting Coronary Stents in China: EVOLVE China Study

Yaling Han - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Promus Element

Ten-year follow-up of the Xience stent in 7655 consecutive patients: single center registry results

Daniela Trabattoni - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Effect of Stent Diameter in Women Undergoing Percutaneous Coronary Intervention with Early- and New-Generation Drug-Eluting Stents: From the Women in Innovation and Drug-Eluting Stents (WIN-DES) Collaboration

Gennaro Giustino - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

A Randomized Comparison of Novel Biodegradable Polymer- and Durable Polymer-Coated Cobalt-Chromium Sirolimus-Eluting Stents: Three-Year Outcomes of the I-LOVE-IT 2 Trial

Bo Xu - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Long-term risk of stent thrombosis and restenosis after treatment with drug-eluting stents: A report from SCAAR

Christian Dworeck - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Mortality and Major Adverse Cardiovascular Events of Polymer Free Drug Coated Stents versus Polymer Based Drug Eluting Stents: A Meta-Analysis of Randomized Controlled Trials

Hemang Panchal - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A novel approach to treat de-novo coronary bifurcation lesion: results of the novel abluminal coated sirolimus eluting dedicated bifurcation stent in first 37 patients from the Bi-Siro study

Sameer Dani - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Rapacan

First generation drug-eluting stent is worse than contemporary bare metal stent after long-term follow-up: A report from SCAAR

Sebastian Volz - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A study of safety and efficacy of biodegradable polymer coated Everolimus-eluting coronary stent system [Everoflex] at intermediate follow-up in real world scenario

Rajasekhar Durgaprasad - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Clinical outcomes of a novel abluminal coated sirolimus eluting stent: 2 years results from en-ABL e-Registry

Sameer Dani - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Very long-term (8-year) angiographic and clinical outcomes after biodegradable polymer-based biolimus-eluting stent implantation

Masanobu Ohya - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

A prospective 9-month comparison of the coronary vasomotor response associated with a biodegradable polymer sirolimus-eluting stent and a bare metal stent

Rodrigo Souza - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

sirolimus

Detection of Valve Thrombosis of Transcatheter Aortic Valve Replacement by 4D-Computed Tomography

Ambarish Gopal - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Warfarin

Use of optical coherence tomography to detect acute coronary syndrome in survivors of out-of-hospital cardiac arrest without ST-segment elevation on ECG.

Philippe DEGRELL - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Imaging and physiology-guided zero contrast percutaneous coronary intervention in advanced chronic kidney disease

Ziad Ali - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ROLE of RESIDUAL ACUTE STENT MALAPPOSITION in percutaneous coronary interventions: a CLI-OPCI project SUBSTUDY

Enrico Romagnoli - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Copyright © 2026. QuantiNova All rights reserved